Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 181–195 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-544 Carbamazepine Free Test This test measures the unbound, pharmacologically active concentration of carbamazepine in serum.	Serum	2–3 weeks	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Free Carbamazepine concentration", "Pharmacologically active drug fraction"] Parameters [{"name": "Free Carbamazepine", "reference_range": "1.0 - 2.5 mg/L (Individualised target range recommended)"}] Preparation ["No specific fasting required", "Continue prescribed medications unless advised otherwise by your doctor"] Indications ["Therapeutic drug monitoring in epilepsy", "Therapeutic drug monitoring in bipolar disorder", "Patients with altered protein binding (e.g., pregnancy, hypoalbuminemia, elderly)", "Suspected carbamazepine toxicity", "Suspected subtherapeutic carbamazepine levels"] Measurement technique Confirm with laboratory Codes LOINC: 3533-7 ICD-10: Z51.81 Clinical summary This test measures the unbound, pharmacologically active concentration of carbamazepine in serum.
TEST-541 Carcinoid Tumor Panel Test This test evaluates for neuroendocrine tumors by measuring key biomarkers associated with carcinoid syndrome.	Serum, Plasma, 24-Hour Urine	3 Business Days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Serotonin", "5-Hydroxyindoleacetic acid (5-HIAA)", "Chromogranin A"] Parameters [{"name": "Serotonin", "reference_range": null}, {"name": "5-Hydroxyindoleacetic acid (5-HIAA)", "reference_range": null}, {"name": "Chromogranin A", "reference_range": null}] Preparation ["Discontinue Proton pump inhibitor (PPI) medications 14 days prior.", "Avoid Banana, kiwi, walnut, avocado, eggplant, pineapple, plum, tomato, and all tomato-containing products 72 hours prior.", "Avoid Fluorouracil, melphalan, paracetamol, acetaminophen, heparin, L-dopa, reserpine, salicylates, chlorpromazine, imipramine, isoniazid, MAO inhibitors, phenothiazines, promethazine, alcohol, caffeine, tea, coffee, tobacco, and strenuous exercise 72 hours prior.", "Consult prescribing physician before changing any medication."] Indications ["Suspicion of neuroendocrine tumor", "Monitoring of known neuroendocrine tumor", "Evaluation of carcinoid syndrome symptoms"] Measurement technique Confirm with laboratory Codes LOINC: 14987-3 ICD-10: E34.0, C7A.00, Z83.49 Clinical summary This test evaluates for neuroendocrine tumors by measuring key biomarkers associated with carcinoid syndrome.
TEST-5364 CARD11 Gene B-Cell Expansion with NF-κB and T-Cell Anergy Genetic Test This genetic test evaluates the entire CARD11 gene for variants associated with B-cell expansion, NF-κB pathway dysregulation, and T-cell anergy.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CARD11 gene variants", "Gain-of-function variants", "Loss-of-function variants", "NF-κB pathway overactivation", "T-cell anergy"] Parameters [{"name": "CARD11 Gene Coverage", "reference_range": "Full gene coverage (exons + splice sites)"}, {"name": "Mean Sequencing Depth", "reference_range": "500x"}, {"name": "Diagnostic Sensitivity", "reference_range": "99.9%"}] Preparation ["A detailed clinical history is required.", "A genetic counselling session is required before sample collection.", "Inform the team of any recent blood transfusions or hematopoietic cell therapy.", "No fasting or medication discontinuation is necessary unless advised by a physician."] Indications ["Diagnosis of primary immunodeficiencies (e.g., BENTA disease, CADINS syndrome)", "Evaluation of unexplained lymphoproliferation", "Assessment of lymphoma risk in patients with immune dysregulation"] Measurement technique Confirm with laboratory Codes LOINC: 55217-0 ICD-10: D84.9 Clinical summary This genetic test evaluates the entire CARD11 gene for variants associated with B-cell expansion, NF-κB pathway dysregulation, and T-cell anergy.
TEST-553 Cardiometabolic Syndrome Panel Advanced Test This test evaluates multiple biomarkers using NGS and biochemical assays to assess risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease.	Peripheral whole blood (serum/plasma)	Same-day if sample received by 2 PM	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic risk scores", "Comprehensive lipid subfractions", "NGSP-certified HbA1c", "Novel inflammatory markers"] Parameters [{"name": "Comprehensive lipid subfractions", "reference_range": null}, {"name": "NGSP-certified HbA1c", "reference_range": null}, {"name": "Novel inflammatory markers", "reference_range": null}, {"name": "Genetic risk scores", "reference_range": null}] Preparation ["Overnight fasting required", "Take all medications as usual unless otherwise directed by your physician"] Indications ["Risk assessment for metabolic syndrome", "Risk assessment for type 2 diabetes", "Risk assessment for cardiovascular disease"] Measurement technique Confirm with laboratory Codes LOINC: 54089-8 ICD-10: E88.81 Clinical summary This test evaluates multiple biomarkers using NGS and biochemical assays to assess risk for metabolic syndrome, type 2 diabetes, and cardiovascular disease.
TEST-561 Carnitine Serum Test This diagnostic test evaluates the levels of free and total carnitine in the serum.	Serum (Peripheral Whole Blood)	2 business days (sample by 9 AM)	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Free Carnitine", "Total Carnitine", "Mitochondrial Fatty Acid Transport"] Parameters [{"name": "Free Carnitine", "reference_range": "25-54 µmol/L (Adults, varies with age/diet)"}, {"name": "Total Carnitine", "reference_range": "35-84 µmol/L (Adults, varies with age/diet)"}] Preparation ["No special preparation, including fasting, is required.", "Inform your healthcare provider about all supplements, especially L-carnitine."] Indications ["Diagnosis of inherited metabolic disorders", "Monitoring of carnitine deficiency", "Screening for primary carnitine deficiency (ICD-10 E71.42)", "Evaluation of mitochondrial fatty acid transport issues"] Measurement technique Confirm with laboratory Codes LOINC: ['50542-3', '50543-1'] ICD-10: E71.42 Clinical summary This diagnostic test evaluates the levels of free and total carnitine in the serum.
TEST-3742 CASR Gene Hyperparathyroidism, Neonatal Severe (Genetic Test) This genetic test identifies pathogenic mutations within the CASR gene, the primary cause of neonatal severe primary hyperparathyroidism (NSHPT).	Whole Blood (Peripheral) or Dried Blood Spot (FTA Card)	3–4 Weeks (Expedited Available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the CASR gene", "Coverage of coding regions and splice sites"] Parameters [] Preparation [] Indications ["Newborns presenting with symptoms suggestive of neonatal severe primary hyperparathyroidism (NSHPT)", "Confirmation of suspected NSHPT based on clinical presentation and biochemical findings (hypercalcemia, elevated PTH)"] Measurement technique Confirm with laboratory Codes LOINC: 51966-2 ICD-10: E21.0 Clinical summary This genetic test identifies pathogenic mutations within the CASR gene, the primary cause of neonatal severe primary hyperparathyroidism (NSHPT).
TEST-4657 CAST Gene Peeling Skin with Leukonychia, Acral Punctate Keratoses, Cheilitis, and Knuckle Pads Genetic Test This test analyzes the CAST gene for mutations associated with hereditary peeling skin syndrome.	Whole Blood or Buccal Swab	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CAST gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Individuals with characteristic clinical features of hereditary peeling skin syndrome", "Confirmed family history of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 83519-7 ICD-10: Q82.8 Clinical summary This test analyzes the CAST gene for mutations associated with hereditary peeling skin syndrome.
TEST-563 Catecholamines & VMA 24-Hour Urine Test This diagnostic test evaluates the levels of catecholamines and their metabolite VMA in a 24-hour urine sample to screen for neuroendocrine tumors.	24-Hour Urine (with HCl preservative)	2 working days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Epinephrine", "Norepinephrine", "Dopamine", "Vanillylmandelic Acid (VMA)"] Parameters [{"name": "Epinephrine", "reference_range": null}, {"name": "Norepinephrine", "reference_range": null}, {"name": "Dopamine", "reference_range": null}, {"name": "Vanillylmandelic Acid (VMA)", "reference_range": null}] Preparation ["Collect all urine over a full 24-hour period into a container with 50% HCl preservative.", "Avoid alpha-blockers, beta-blockers, amphetamines, MAO inhibitors, nicotine, tea/coffee, chocolate, vanilla, bananas, and alcohol for 72 hours before starting collection.", "Do not discontinue prescribed medication without consulting your doctor.", "Keep the container refrigerated during collection."] Indications ["Suspected pheochromocytoma", "Suspected paraganglioma", "Evaluation of unexplained hypertension", "Screening for neuroendocrine tumors"] Measurement technique Confirm with laboratory Codes LOINC: 94304-3 ICD-10: E27.5 Clinical summary This diagnostic test evaluates the levels of catecholamines and their metabolite VMA in a 24-hour urine sample to screen for neuroendocrine tumors.
TEST-567 Catecholamines Fractionated 24-Hour Urine Test This test measures the levels of catecholamines (norepinephrine, epinephrine, dopamine) and their metabolites in a 24-hour urine collection.	24-Hour Urine	2 Days (sample collected Wed/Sat by 9 AM)	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Norepinephrine", "Epinephrine", "Dopamine"] Parameters [{"name": "Norepinephrine", "reference_range": null}, {"name": "Epinephrine", "reference_range": null}, {"name": "Dopamine", "reference_range": null}] Preparation ["Mandatory 72-hour pre-test abstinence from specific medications (Alpha-one blockers, Aminophylline, Amphetamines, Ampicillin, Beta-blockers, Ephedrine, Imipramine, Methyldopa, MAO inhibitors, Nicotine, Phenacetin, Phenothiazine, Theophylline, Vasodilators, Aspirin, PAS, Alpha-2 agonists, Bromocriptine, Calcium channel blockers, Clofibrate, Propranolol, Penicillin, Reserpine, Thyroxine, Alpha-methyldopa, Isoproterenol, Labetalol, Mandelamine, Paracetamol (high dose), Cimetidine, Metoclopramide).", "Strictly avoid vigorous exercise, alcoholic beverages, tea, coffee, and tobacco for 72 hours before and during urine collection.", "Consult physician before pausing any medications.", "Collect a 24-hour urine specimen using the provided preservative kit."] Indications ["Suspected pheochromocytoma", "Suspected paraganglioma", "Monitoring known neuroendocrine tumors", "Evaluation of hypertension"] Measurement technique Confirm with laboratory Codes LOINC: 15061-9 ICD-10: R82.5, C74.1 Clinical summary This test measures the levels of catecholamines (norepinephrine, epinephrine, dopamine) and their metabolites in a 24-hour urine collection.
TEST-559 Catecholamines Fractionated Random Urine Test This diagnostic test evaluates the levels of fractionated catecholamines (dopamine, epinephrine, norepinephrine) in a random urine sample.	Random Urine	2 business days (sample cutoff Wed/Sat by 9 AM)	600.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Dopamine", "Epinephrine", "Norepinephrine"] Parameters [{"name": "Dopamine", "reference_range": null}, {"name": "Epinephrine", "reference_range": null}, {"name": "Norepinephrine", "reference_range": null}] Preparation ["Abstain from certain medications, alcohol, and tobacco for 72 hours", "Consult physician for safe temporary cessation of medications"] Indications ["Suspected pheochromocytoma", "Suspected paraganglioma", "Suspected neuroblastoma", "Evaluation of unexplained hypertension"] Measurement technique Confirm with laboratory Codes LOINC: 18307-2 ICD-10: E27.5 Clinical summary This diagnostic test evaluates the levels of fractionated catecholamines (dopamine, epinephrine, norepinephrine) in a random urine sample.
TEST-2 Catecholamines Plasma Test This test measures plasma levels of catecholamines (epinephrine, norepinephrine, dopamine) to aid in the diagnosis of neuroendocrine tumors.	Plasma	7 days	1,500.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Epinephrine", "Norepinephrine", "Dopamine"] Parameters [{"name": "Epinephrine", "reference_range": null}, {"name": "Norepinephrine", "reference_range": null}, {"name": "Dopamine", "reference_range": null}] Preparation ["Avoid specific medications (aldomet, labetalol, isoproterenol, beta-blockers, amphetamines, ephedrine, nicotine, theophylline, vasodilators, MAO inhibitors) for 72 hours prior", "Avoid smoking for 72 hours prior", "Avoid intense stress for 72 hours prior", "Rest supine for 30 minutes after IV cannula insertion"] Indications ["Suspected pheochromocytoma", "Suspected paraganglioma", "Suspected neuroblastoma", "Evaluation of treatment-resistant hypertension", "Family history of MEN2, VHL, or neurofibromatosis type 1"] Measurement technique Confirm with laboratory Codes LOINC: 21474-9 ICD-10: D44.2 Clinical summary This test measures plasma levels of catecholamines (epinephrine, norepinephrine, dopamine) to aid in the diagnosis of neuroendocrine tumors.
TEST-5254 CAV3 Gene Distal Myopathy (Tateyama Type) Genetic Test This test identifies pathogenic variants in the CAV3 gene associated with distal myopathy, Tateyama type.	Peripheral whole blood (EDTA) or extracted DNA or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CAV3 gene", "Coding region analysis"] Parameters [] Preparation ["Provide detailed clinical history", "Undergo pre-test genetic counselling", "No dietary or medication restrictions"] Indications ["Suspected distal myopathy, Tateyama type", "Family history of similar symptoms", "Confirmation of genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G71.0 Clinical summary This test identifies pathogenic variants in the CAV3 gene associated with distal myopathy, Tateyama type.
TEST-2482 CBL Gene Genetic Test for Noonan Syndrome‑like Disorder with or without Juvenile Myelomonocytic Leukemia This test evaluates the entire coding region and splice sites of the CBL gene for germline mutations.	Peripheral whole blood (3–5 mL in EDTA tube) or FTA card dried blood spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the CBL gene", "Coding region and splice sites of the CBL gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Clinical suspicion of Noonan syndrome-like disorder", "Family history of Noonan syndrome-like disorder or JMML", "Evaluation of predisposition to JMML"] Measurement technique Confirm with laboratory Codes LOINC: 89539-1 ICD-10: Q87.19 Clinical summary This test evaluates the entire coding region and splice sites of the CBL gene for germline mutations.
TEST-3228 CBLIF Gene Intrinsic Factor Deficiency Genetic Test This genetic test identifies pathogenic variants in the CBLIF gene associated with intrinsic factor deficiency and potential pernicious anemia.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBLIF gene sequence", "Pathogenic variants in CBLIF"] Parameters [] Preparation ["No specific fasting required", "Inform lab of current medications"] Indications ["Suspected hereditary intrinsic factor deficiency", "Confirmation of genetic cause for B12 deficiency", "Family cascade screening"] Measurement technique Confirm with laboratory Codes LOINC: 55231-3 ICD-10: D51.0 Clinical summary This genetic test identifies pathogenic variants in the CBLIF gene associated with intrinsic factor deficiency and potential pernicious anemia.
TEST-4001 CBS Gene Homocystinuria due to Cystathionine Beta‑Synthase Deficiency Genetic Test This genetic test identifies disease-causing variants in the CBS gene, confirming a diagnosis of classic homocystinuria.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CBS gene variants", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Personal or family history of unexplained thromboembolic events", "Early-onset stroke", "Myocardial infarction before age 50", "Deep vein thrombosis", "Pulmonary embolism", "Known consanguinity with homocystinuria"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E72.11 Clinical summary This genetic test identifies disease-causing variants in the CBS gene, confirming a diagnosis of classic homocystinuria.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories